Sphera Funds Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.22M | Buy |
186,000
+100,000
| +116% | +$2.66M | 0.83% | 45 |
|
|
2025
Q4 | $2.14M | Hold |
86,000
| – | – | 0.41% | 73 |
|
|
2025
Q3 | $2.19M | Hold |
86,000
| – | – | 0.46% | 67 |
|
|
2025
Q2 | $2.08M | Sell |
86,000
-4,000
| -4% | -$93.3K | 0.49% | 65 |
|
|
2025
Q1 | $2.28M | Hold |
90,000
| – | – | 0.53% | 60 |
|
|
2024
Q4 | $2.39M | Hold |
90,000
| – | – | 0.43% | 73 |
|
|
2024
Q3 | $2.6M | Hold |
90,000
| – | – | 0.41% | 69 |
|
|
2024
Q2 | $2.52M | Hold |
90,000
| – | – | 0.34% | 80 |
|
|
2024
Q1 | $2.5M | Hold |
90,000
| – | – | 0.35% | 71 |
|
|
2023
Q4 | $2.59M | Hold |
90,000
| – | – | 0.42% | 66 |
|
|
2023
Q3 | $2.99M | Sell |
90,000
-50,000
| -36% | -$1.77M | 0.54% | 58 |
|
|
2023
Q2 | $5.14M | Hold |
140,000
| – | – | 0.8% | 50 |
|
|
2023
Q1 | $5.71M | Buy |
+140,000
| New | +$6.05M | 0.95% | 36 |
|
|
2022
Q2 | – | Sell |
-515,070
| Closed | -$26.7M | – | 74 |
|
|
2022
Q1 | $26.7M | Buy |
515,070
+286,542
| +125% | +$14.9M | 3.77% | 7 |
|
|
2021
Q4 | $13.5M | Sell |
228,528
-878,000
| -79% | -$43.5M | 1.48% | 18 |
|
|
2021
Q3 | $47.6M | Buy |
+1,106,528
| New | +$49M | 4% | 5 |
|
|
2020
Q2 | – | Sell |
-579,700
| Closed | -$19.7M | – | 103 |
|
|
2020
Q1 | $18M | Buy |
+579,700
| New | +$19.8M | 2.25% | 13 |
|
|
2018
Q3 | – | Sell |
-411,060
| Closed | -$14.1M | – | 126 |
|
|
2018
Q2 | $14.1M | Sell |
411,060
-210,800
| -34% | -$7.2M | 1.95% | 14 |
|
|
2018
Q1 | $20.9M | Buy |
621,860
+210,800
| +51% | +$7.25M | 3.18% | 7 |
|
|
2017
Q4 | $14.1M | Hold |
411,060
| – | – | 1.66% | 11 |
|
|
2017
Q3 | $13.9M | Hold |
411,060
| – | – | 1.99% | 9 |
|
|
2017
Q2 | $13.1M | Hold |
411,060
| – | – | 2.23% | 11 |
|
|
2017
Q1 | $13.3M | Buy |
+411,060
| New | +$13M | 2.61% | 10 |
|
|
2016
Q4 | – | Sell |
-449,649
| Closed | -$14.4M | – | 118 |
|
|
2016
Q3 | $14.4M | Hold |
449,649
| – | – | 2.35% | 10 |
|
|
2016
Q2 | $15M | Sell |
449,649
-1,054,000
| -70% | -$33.6M | 3.9% | 7 |
|
|
2016
Q1 | $42.3M | Buy |
1,503,649
+263,500
| +21% | +$7.53M | 9.17% | 2 |
|
|
2015
Q4 | $38M | Buy |
1,240,149
+635,139
| +105% | +$20M | 5.56% | 4 |
|
|
2015
Q3 | $18M | Sell |
605,010
-316,200
| -34% | -$10.1M | 2.3% | 9 |
|
|
2015
Q2 | $29.3M | Sell |
921,210
-158,100
| -15% | -$5.15M | 2.87% | 6 |
|
|
2015
Q1 | $35.6M | Buy |
1,079,310
+158,100
| +17% | +$5.03M | 3.71% | 4 |
|
|
2014
Q4 | $27.2M | Sell |
921,210
-421,600
| -31% | -$12.1M | 4.64% | 3 |
|
|
2014
Q3 | $37.7M | Buy |
1,342,810
+652,866
| +95% | +$18.3M | 4.65% | 3 |
|
|
2014
Q2 | $19.4M | Sell |
689,944
-210,800
| -23% | -$6.01M | 4.79% | 5 |
|
|
2014
Q1 | $27.4M | Buy |
900,744
+160,313
| +22% | +$4.78M | 6.27% | 5 |
|
|
2013
Q4 | $21.5M | Buy |
+740,431
| New | +$21.5M | 5.99% | 3 |
|
Other funds holding PFE
VCM
VPM
Sphera Funds Management's PFE Position: Q1 2026 in Review
Sphera Funds Management increased its Pfizer (PFE) stake by 116% in Q1 2026, buying an estimated $2.66M and bringing the position to 186,000 shares worth $5.22M. The position accounts for 0.83% of the portfolio, ranked #45.
Sphera Funds Management first reported a position in PFE in Q4 2013 and has held it in 35 quarters since. The position peaked at $47.6M in Q3 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Sphera Funds Management held 186,000 shares of Pfizer worth $5.22M as of Q1 2026.
- Sphera Funds Management bought 100,000 Pfizer shares in Q1 2026, an estimated $2.66M.
- Pfizer made up 0.83% of Sphera Funds Management's portfolio in Q1 2026, its #45 holding.
- Sphera Funds Management first reported a position in Pfizer in Q4 2013 and has held it in 35 quarters since.
- Sphera Funds Management's Pfizer position peaked at $47.6M in Q3 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.